• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Study for the cellular signal transduction of Neurofibromatosis Type 1 and Type 2 tumor suppressor gene products to establish the medical molecular target for NF1 and NF2

Research Project

Project/Area Number 16390413
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Cerebral neurosurgery
Research InstitutionKumamoto University

Principal Investigator

ARAKI Norie  Kumamoto University, Graduate School of Medical Sciences, Tumor Genetics & Biology, Associate Professor, 大学院・医学薬学研究部, 講師 (80253722)

Co-Investigator(Kenkyū-buntansha) SAYA Hideyuki  Kumamoto University, Graduate School of Medical Sciences, Tumor Genetics & Biology, Professor, 大学院・医学薬学研究部, 教授 (80264282)
Project Period (FY) 2004 – 2005
Project Status Completed (Fiscal Year 2005)
Budget Amount *help
¥13,700,000 (Direct Cost: ¥13,700,000)
Fiscal Year 2005: ¥6,600,000 (Direct Cost: ¥6,600,000)
Fiscal Year 2004: ¥7,100,000 (Direct Cost: ¥7,100,000)
KeywordsNeurofibromatosis Type 1 / NF1 / Neurofibromin / Neurofibromatosis Type 2 / NF2 / Merlin / Proteomics / brain tumor / 腫瘍抑制遺伝子
Research Abstract

The neurofibromatosis type 1 (NF1) and type 2 (NF2) are autosomal dominantly inherited disorders, and strongly associated with development of intracranial tumors including bilateral vestibular schwannomas, meningiomas and gliomas. To elucidate the biological function of NF1 and NF2 gene products, and, we analyzed their cellular signal transductions by using siRNA techniques and proteomic strategies. 1)NF1 ; NF1 siRNA induces characteristic morphological changes, such as excessive actin stress fiber formation, with elevated phosphorylation levels of coffin, which regulates actin cytoskeletal reorganization by depolymerizing and severing actin filaments, and that was promoted by the activation of a Rho-ROCK-LIMK2 pathway, which requires Ras activation. Fifty three proteins associating to neurofibromin were identified with the quantitative differential proteomic strategy (iTRAQ). These proteins contain collapsin response mediator protein-2 (CRMP-2), calmodulin (CaM), 14-3-3 proteins, Micr … More otubule-associated proteins, coffilin etc. In PC12 cells, the associations of CRMP2 and tubulin to neurofibromin were regulated by their phosphorylation manners. NF1 SiRNA significantly inhibited the neurite extension of PC12 cells, which was correlated with the regulation of CRMP-2 phosphorylations via GSK-3b, Rho-kinase, and other kinases. Neurofibromin has significant roles in the machinery regulating cellular cytoskeletal reorganization, which affects cell motility, adhesion, and differentiations. 2)NF2 ; 28 cellular binding proteins of merlin were identified, and focused on DNA repair enzymes such as poly ADP-ribose polymerase, DNA-PK subunits Ku-antigen 85 and 70. The N-terminal (19-339) region of merlin is essential for their interaction. Subcellular co-localizations of merlin and PARP were observed mainly in their nuclear region with a nuclear export signal (NES) dependent manner of merlin. This nuclear accumulation increased with cellular DNA damages, whereas MEF (PARP-/-) could not accumulate merlin in their nuclear region. These results suggest that merlin is a cytoplasmic-nuclear shuttling protein directed by its NES-dependent transport pathway being associated with PARP. Functional regulations of NF proteins via their cellular associating proteins are essential, and their abnormal regulations caused by NF gene aberrations may be implicated in NF-related pathogenesis. Less

Report

(3 results)
  • 2005 Annual Research Report   Final Research Report Summary
  • 2004 Annual Research Report
  • Research Products

    (31 results)

All 2006 2005 2004

All Journal Article (24 results) Book (3 results) Patent(Industrial Property Rights) (4 results)

  • [Journal Article] AM-3K, an Anti-macrophage Antibody, Recognizes CD163, a Molecule Associated with an Anti-inflammatory Macrophage Phenotype.2006

    • Author(s)
      Komohara Y, Hirahara J, Horikawa T, Kawamura K, Kiyota E, Sakashita N, Araki N.Takeya M.
    • Journal Title

      J Histochem Cytochem. (in press)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] AM-3K, an Anti-macrophage Antibody, Recognizes CD163, a Molecule Associated with an Anti-inflammatory Macrophage Phenotype2006

    • Author(s)
      Komohara, Y. et al.
    • Journal Title

      J Histochem Cytochem. (In press)

    • Related Report
      2005 Annual Research Report
  • [Journal Article] proteomic differential displayの最前線2005

    • Author(s)
      荒木令江
    • Journal Title

      疾患プロテオミクスの最前線 2

      Pages: 58-69

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] 脳疾患の病態プロテオミクス2005

    • Author(s)
      荒木令江
    • Journal Title

      疾患プロテオミクスの最前線 2

      Pages: 233-243

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] プロテオミクスによる疾患研究と臨床診断に向かう戦略2005

    • Author(s)
      荒木令江
    • Journal Title

      疾患プロテオミクスの最前線 2

      Pages: 26-30

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary 2004 Annual Research Report
  • [Journal Article] The neurofibromatosis type 1 gene product neurofibromin enhances cell mobility by regulating actin filament dynamics via the Rh0-ROCK-LIMK2- cofilin pathway.2005

    • Author(s)
      Ozawa, et al.
    • Journal Title

      Journal of Biological Chemistry 280・47

      Pages: 39524-39533

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] AM-3K, an Anti-macrophage Antibody, Recognizes CD163, a Molecule Associated with an Anti-inflammatory Macrophage PHenotype2005

    • Author(s)
      Komohara, Y, et al.
    • Journal Title

      J Histochem Cytochem. (In press)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Observation of the intracellular behavior of recombinant Y ersinia pseudotuberculosis invasin protein.2005

    • Author(s)
      Koga, H. et al.
    • Journal Title

      Microbiol Immunol. 49・4

      Pages: 297-302

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] 二次元電気泳動に関すること2005

    • Author(s)
      荒木令江.
    • Journal Title

      タンパク質研究なるほどQ&A

      Pages: 106-111

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Annual Research Report 2005 Final Research Report Summary
  • [Journal Article] 脳腫瘍の病態プロテオミクスで見えてくる新たなシグナル伝達経路2005

    • Author(s)
      荒木令江.
    • Journal Title

      実験医学 123・7

      Pages: 1050-1058

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Annual Research Report 2005 Final Research Report Summary
  • [Journal Article] プロテオミクスを用いた病態解明の手法2005

    • Author(s)
      荒木令江.
    • Journal Title

      分子心血管病 6・6

      Pages: 607-618

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Annual Research Report 2005 Final Research Report Summary
  • [Journal Article] Observation of the Intracellular Behavior of Recombinant Yersinia pseudotuberculosis Invasin Protein.2005

    • Author(s)
      Koga H, Izawa I, Araki N, Saya H, Mimori T.
    • Journal Title

      Microbiol Immunol. 49(4)

      Pages: 297-302

    • NAID

      10015527670

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway.2005

    • Author(s)
      Ozawa T, Araki N, Yunoue S, Tokuo H, Feng L, Patrakitkomjom S, Hara T, Ichikawa Y, Matsumoto K, Fujii K, Saya H
    • Journal Title

      J Biol Chem 280

      Pages: 39524-39533

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway.2005

    • Author(s)
      Ozawa, T. et al.
    • Journal Title

      Journal of Biological Chemistry 280・47

      Pages: 39524-39533

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Observation of the intracellular behavior of recombinant Yersinia pseudotuberculosis invasin protein.2005

    • Author(s)
      Koga, H. et al.
    • Journal Title

      Microbiol Immunol. 49・4

      Pages: 297-302

    • Related Report
      2005 Annual Research Report
  • [Journal Article] PKA phosphorylation and 14-3-3 interaction regulate the function of neurofibromatosis type I tumor suppressor, neurofibromin.2004

    • Author(s)
      Feng L.et al.
    • Journal Title

      FEBS Lett 667・1-3

      Pages: 275-282

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease2004

    • Author(s)
      Kurihara N. et al.
    • Journal Title

      J Bone Miner Res 19・7

      Pages: 1154-1164

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary 2004 Annual Research Report
  • [Journal Article] Methods for protein purification from biological samples2004

    • Author(s)
      Araki, N.
    • Journal Title

      Tanpakushitsu Kakusan Koso 49・11

      Pages: 1495-1505

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary 2004 Annual Research Report
  • [Journal Article] PKA phosphorylation and 14-3-3 interaction regulate the function of neurofibromatosis type I tumor suppressor, neurofibromin.2004

    • Author(s)
      Feng L, Yunoue S, Tokuo H, Ozawa T, Zhang D, Patrakitkomjorn S, Ichimura T, Saya H, Araki N^*.
    • Journal Title

      FEBS Lett. 557(1-3)

      Pages: 275-282

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease.2004

    • Author(s)
      Kurihara N, Reddy SV, Araki N, Ishizuka S, Ozono K, Cornish J, Cundy T, Singer FR, Roadman GD.
    • Journal Title

      J Bone Miner Res. 19(7)

      Pages: 1154-1164

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Methods for protein purification from biological samples.2004

    • Author(s)
      Araki N^*.
    • Journal Title

      Tanpakushitsu Kakusan Koso. 49(11)

      Pages: 1495-1505

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] PKA phosphorylation and 14-3-3 interaction regulate the function of neurofibromatosis type I tumor suppressor, neurofibromin.2004

    • Author(s)
      Feng L.et al.
    • Journal Title

      FEBS Lett 557・1-3

      Pages: 275-282

    • Related Report
      2004 Annual Research Report
  • [Journal Article] 「in vitroラベル法」オンラインLC-MS法による発現プロファイル解析2004

    • Author(s)
      荒木令江
    • Journal Title

      決定版!プロテオーム解析マニュアル

      Pages: 111-124

    • Related Report
      2004 Annual Research Report
  • [Journal Article] 「脳腫瘍の病態プロテオミクスで見えてくる新たなシグナル伝達経路」プロテオミクスでみえてくる生命機能の新たなメカニズム2004

    • Author(s)
      荒木令江
    • Journal Title

      実験医学 23・7

      Pages: 1050-1058

    • Related Report
      2004 Annual Research Report
  • [Book] 疾患プロテオミクスの最前線2005

    • Author(s)
      荒木令江 編集
    • Total Pages
      402
    • Publisher
      Medical DO社
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Annual Research Report 2005 Final Research Report Summary
  • [Book] 「in vitroラベル法」オンラインLC-MS法による発現プロファイル解析決定版!プロテオーム解析マニュアル2004

    • Author(s)
      荒木令江
    • Publisher
      羊土社
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Book] 疾患プロテオミクスの最前線2004

    • Author(s)
      荒木令江, 戸田年総 編集
    • Total Pages
      402
    • Publisher
      株式会社メディカルドゥ
    • Related Report
      2004 Annual Research Report
  • [Patent(Industrial Property Rights)] 解析プログラム、プロテインチップ、プロテインチップの製造方法、および、抗体カクテル2006

    • Inventor(s)
      荒木令江, 他2名
    • Industrial Property Rights Holder
      熊本TLO
    • Industrial Property Number
      2006-072392
    • Filing Date
      2006-03-16
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Patent(Industrial Property Rights)] 情報処理システム、および、情報処理プログラム2006

    • Inventor(s)
      荒木令江, 他2名
    • Industrial Property Rights Holder
      熊本TLO
    • Industrial Property Number
      2006-072392
    • Filing Date
      2006-03-16
    • Related Report
      2005 Annual Research Report
  • [Patent(Industrial Property Rights)] 情報処理システム、および、情報処理プログラム2005

    • Inventor(s)
      荒木令江
    • Industrial Property Rights Holder
      (財)くまもとテクノ産業財団
    • Industrial Property Number
      2005-076106
    • Filing Date
      2005-03-16
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Patent(Industrial Property Rights)] 情報処理システム、および、情報処理プログラム2005

    • Inventor(s)
      荒木 令江
    • Industrial Property Rights Holder
      (財)くまもとテクノ産業財団
    • Industrial Property Number
      2005-076106
    • Filing Date
      2005-03-16
    • Related Report
      2004 Annual Research Report

URL: 

Published: 2004-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi